25. Expression of p21 and p27 cell cycle proteins in neoplasms of central nervous system. An immunohistochemical study

F. Giangaspero, F. Morigi, S. Cerasoli, S. Naldi

Research output: Contribution to journalArticle

Abstract

The cell cycle proteins p21 and p27 are inhibitors of cyclin-dependent kinase and are negative regulators of progression of G1 phase. Few study have focused on expression of these proteins in CNS tumors. The following series of neoplasms were evaluated: 21 malignant astrocytomas (grade III and IV, WHO), 21 oligodendrogliomas, 2 astrocytomas (grade II, WHO), 4 pilocytic astrocytomas, 2 neurocytomas. Immunohistochemistry was performed on formalin-fixed, paraffin-embedded material using p27 and p21 mouse monoclonal antibodies (Neo Markers). p27 and p21 staining was evaluated semiquantitatively. p27 was expressed in: 5/21 (24%) malignant astrocytomas, 1/2 (50%) astrocytomas, 3/4 (75%) pilocytic astrocytomas, 17/21 (81%) of oligodendrogliomas and 2/2 (100%) neurocitoma. p21 was not significatively expressed in any cases except in 1 out 21 (5%) oligodendrogliomas. Our preliminary results indicate that p27 is significantly expressed in low grade neoplasms. Moreover its high expression in oligodendrogliomas support their distinctive biology from diffuse astrocytomas.

Original languageEnglish
Pages (from-to)248
Number of pages1
JournalItalian Journal of Neurological Sciences
Volume18
Issue number4
Publication statusPublished - 1997

Fingerprint

Central Nervous System Neoplasms
Cell Cycle Proteins
Astrocytoma
Oligodendroglioma
Neurocytoma
Cyclin-Dependent Kinase Inhibitor p21
Cyclin-Dependent Kinase Inhibitor p27
Neoplasms
G1 Phase
Glioblastoma
Paraffin
Formaldehyde
Immunohistochemistry
Monoclonal Antibodies
Staining and Labeling

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

25. Expression of p21 and p27 cell cycle proteins in neoplasms of central nervous system. An immunohistochemical study. / Giangaspero, F.; Morigi, F.; Cerasoli, S.; Naldi, S.

In: Italian Journal of Neurological Sciences, Vol. 18, No. 4, 1997, p. 248.

Research output: Contribution to journalArticle

@article{30cd23e56b1f49b39dbe9b8e6a4a672c,
title = "25. Expression of p21 and p27 cell cycle proteins in neoplasms of central nervous system. An immunohistochemical study",
abstract = "The cell cycle proteins p21 and p27 are inhibitors of cyclin-dependent kinase and are negative regulators of progression of G1 phase. Few study have focused on expression of these proteins in CNS tumors. The following series of neoplasms were evaluated: 21 malignant astrocytomas (grade III and IV, WHO), 21 oligodendrogliomas, 2 astrocytomas (grade II, WHO), 4 pilocytic astrocytomas, 2 neurocytomas. Immunohistochemistry was performed on formalin-fixed, paraffin-embedded material using p27 and p21 mouse monoclonal antibodies (Neo Markers). p27 and p21 staining was evaluated semiquantitatively. p27 was expressed in: 5/21 (24{\%}) malignant astrocytomas, 1/2 (50{\%}) astrocytomas, 3/4 (75{\%}) pilocytic astrocytomas, 17/21 (81{\%}) of oligodendrogliomas and 2/2 (100{\%}) neurocitoma. p21 was not significatively expressed in any cases except in 1 out 21 (5{\%}) oligodendrogliomas. Our preliminary results indicate that p27 is significantly expressed in low grade neoplasms. Moreover its high expression in oligodendrogliomas support their distinctive biology from diffuse astrocytomas.",
author = "F. Giangaspero and F. Morigi and S. Cerasoli and S. Naldi",
year = "1997",
language = "English",
volume = "18",
pages = "248",
journal = "Italian Journal of Neurological Sciences",
issn = "0392-0461",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - 25. Expression of p21 and p27 cell cycle proteins in neoplasms of central nervous system. An immunohistochemical study

AU - Giangaspero, F.

AU - Morigi, F.

AU - Cerasoli, S.

AU - Naldi, S.

PY - 1997

Y1 - 1997

N2 - The cell cycle proteins p21 and p27 are inhibitors of cyclin-dependent kinase and are negative regulators of progression of G1 phase. Few study have focused on expression of these proteins in CNS tumors. The following series of neoplasms were evaluated: 21 malignant astrocytomas (grade III and IV, WHO), 21 oligodendrogliomas, 2 astrocytomas (grade II, WHO), 4 pilocytic astrocytomas, 2 neurocytomas. Immunohistochemistry was performed on formalin-fixed, paraffin-embedded material using p27 and p21 mouse monoclonal antibodies (Neo Markers). p27 and p21 staining was evaluated semiquantitatively. p27 was expressed in: 5/21 (24%) malignant astrocytomas, 1/2 (50%) astrocytomas, 3/4 (75%) pilocytic astrocytomas, 17/21 (81%) of oligodendrogliomas and 2/2 (100%) neurocitoma. p21 was not significatively expressed in any cases except in 1 out 21 (5%) oligodendrogliomas. Our preliminary results indicate that p27 is significantly expressed in low grade neoplasms. Moreover its high expression in oligodendrogliomas support their distinctive biology from diffuse astrocytomas.

AB - The cell cycle proteins p21 and p27 are inhibitors of cyclin-dependent kinase and are negative regulators of progression of G1 phase. Few study have focused on expression of these proteins in CNS tumors. The following series of neoplasms were evaluated: 21 malignant astrocytomas (grade III and IV, WHO), 21 oligodendrogliomas, 2 astrocytomas (grade II, WHO), 4 pilocytic astrocytomas, 2 neurocytomas. Immunohistochemistry was performed on formalin-fixed, paraffin-embedded material using p27 and p21 mouse monoclonal antibodies (Neo Markers). p27 and p21 staining was evaluated semiquantitatively. p27 was expressed in: 5/21 (24%) malignant astrocytomas, 1/2 (50%) astrocytomas, 3/4 (75%) pilocytic astrocytomas, 17/21 (81%) of oligodendrogliomas and 2/2 (100%) neurocitoma. p21 was not significatively expressed in any cases except in 1 out 21 (5%) oligodendrogliomas. Our preliminary results indicate that p27 is significantly expressed in low grade neoplasms. Moreover its high expression in oligodendrogliomas support their distinctive biology from diffuse astrocytomas.

UR - http://www.scopus.com/inward/record.url?scp=33746371418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746371418&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33746371418

VL - 18

SP - 248

JO - Italian Journal of Neurological Sciences

JF - Italian Journal of Neurological Sciences

SN - 0392-0461

IS - 4

ER -